Ocean Biomedical Inc (OCEA)

$1.6

+0.13

(+8.84%)

Market is closed - opens 7 PM, 04 Jun 2024

Insights on Ocean Biomedical Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 72.6% return, outperforming this stock by 143.5%

Performance

  • $1.45
    $1.75
    $1.60
    downward going graph

    9.38%

    Downside

    Day's Volatility :17.14%

    Upside

    8.57%

    downward going graph
  • $0.52
    $7.96
    $1.60
    downward going graph

    67.5%

    Downside

    52 Weeks Volatility :93.47%

    Upside

    79.9%

    downward going graph

Returns

PeriodOcean Biomedical IncIndex (Russel 2000)
3 Months
-60.78%
0.0%
6 Months
95.26%
0.0%
1 Year
-71.07%
0.0%
3 Years
-73.47%
-22.6%

Highlights

Market Capitalization
54.4M
Book Value
- $2.21
Earnings Per Share (EPS)
-3.0
Wall Street Target Price
18.5
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-681.99%
Return On Equity TTM
0.0%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
Diluted Eps TTM
-3.0
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Ocean Biomedical Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 1056.25%

Current $1.60
Target $18.50

Technicals Summary

Sell

Neutral

Buy

Ocean Biomedical Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ocean Biomedical Inc
Ocean Biomedical Inc
14.7%
95.26%
-71.07%
-73.47%
-73.47%
Moderna, Inc.
Moderna, Inc.
21.03%
85.08%
14.68%
-28.27%
659.22%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
3.22%
20.18%
31.88%
93.3%
227.58%
Novo Nordisk A/s
Novo Nordisk A/s
8.85%
34.38%
71.83%
235.07%
463.44%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
16.81%
34.1%
40.6%
123.97%
174.53%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ocean Biomedical Inc
Ocean Biomedical Inc
NA
NA
NA
0.0
0.0
-6.82
NA
-2.21
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.14
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
28.89
28.89
1.46
44.13
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
46.97
46.97
2.36
3.5
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
29.59
29.59
0.53
17.08
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ocean Biomedical Inc
Ocean Biomedical Inc
Buy
$54.4M
-73.47%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$54.6B
659.22%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$108.0B
227.58%
28.89
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$602.6B
463.44%
46.97
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$117.5B
174.53%
29.59
39.46%

Company Information

Organization
Ocean Biomedical Inc
Employees
0
CEO
Ms. Elizabeth Ng M.B.A.
Industry
Miscellaneous

FAQs